Live
- BJP MLA warns of protest over Panchamasali reservation demand
- Sunspots and solar flares can affect Earth’s surface
- Discom staff neglect jungle clearance at poles
- Experts at COP29 urge India to tackle short-lived climate pollutants
- AGP inducts new locomotive
- Visakhapatnam: 31-year-old attacks girl for refusing his love
- MyVoice: Views of our readers 15th November 2024
- NWKRTC embraces digital payments to enhance passenger experience
- Beating plastic pollution,a serious task ahead
- Executive cannot ‘bulldoze’ judiciary: SC
Dr Reddy's launches generic hypotensive injection in US
Drug firm Dr Reddy's Laboratories on Monday said it has launched in the US Sodium Nitroprusside injection used for immediate reduction of blood pressure in hypertensive crises.
Hyderabad: Drug firm Dr Reddy's Laboratories on Monday said it has launched in the US Sodium Nitroprusside injection used for immediate reduction of blood pressure in hypertensive crises.
The company has launched generic Sodium Nitroprusside injection, 50 mg/2 ml (25 mg/ml) single-dose vial after getting approval from the United States Food and Drug Administration (USFDA), Dr Reddy's Labs said in a filing to the BSE.
The product is a generic version of Hospira Inc's Nitropress injection, 50 mg/2ml, it added. As per IQVIA Health data, Nitropress brand and generics had US sales of around $8 million MAT for the twelve months to October 2019, Dr Reddy's said.
Sodium Nitroprusside is indicated for the immediate reduction of blood pressure of adult and pediatric patients in hypertensive crises.
